These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1752152)

  • 61. Massively distended, necrotic and hemorrhagic gallbladder in a long-term octreotide-treated patient with added everolimus.
    Bergeron E; Bensoussan M
    Int J Surg Case Rep; 2019; 61():107-110. PubMed ID: 31352317
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Proceedings of the discussion: 'Tolerability and safety of Sandostatin'.
    Popovic V; Chayvialle JA; Wass JA
    Digestion; 1993; 54 Suppl 1():104-6. PubMed ID: 8359564
    [No Abstract]   [Full Text] [Related]  

  • 63. Acute pancreatitis following octreotide withdrawal.
    Sadoul JL; Benchimol D; Thyss A; Freychet P
    Am J Med; 1991 Jun; 90(6):763-4. PubMed ID: 2042694
    [No Abstract]   [Full Text] [Related]  

  • 64. Slow intestinal transit and gallstone formation.
    Hussaini SH; Pereira SP; Dowling RH; Wass JA
    Lancet; 1993 Mar; 341(8845):638. PubMed ID: 8094871
    [No Abstract]   [Full Text] [Related]  

  • 65. Ultrasonography of the gallbladder in pregnancy.
    Bartoli E; Calonaci N; Nenci R
    Gastrointest Radiol; 1984; 9(1):35-8. PubMed ID: 6724237
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Recurrent transient gallbladder wall thickening associated with interleukin-2 chemotherapy.
    Dickey KW; Barth RA; Stewart JA
    J Clin Ultrasound; 1993 Jan; 21(1):58-61. PubMed ID: 8478450
    [No Abstract]   [Full Text] [Related]  

  • 67. Complications of long-acting somatostatin analogue therapy.
    Jackson JA
    Am J Med; 1989 Apr; 86(4):512-3. PubMed ID: 2929652
    [No Abstract]   [Full Text] [Related]  

  • 68. Value of prone positioning in the ultrasonographic diagnosis of gallstones: prospective study.
    Hough DM; Glazebrook KN; Paulson EK; Bowie JD; Foster WL
    J Ultrasound Med; 2000 Sep; 19(9):633-8. PubMed ID: 10972560
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Congestive heart failure worsening with octreotide in acromegalic patient.
    Leclerq F; Fille A; Albat B; Bringer J; Grolleau R; Jaffiol C
    Lancet; 1991 Nov; 338(8777):1272-3. PubMed ID: 1682667
    [No Abstract]   [Full Text] [Related]  

  • 70. Incidence of gall stone formation in acromegalic patients on octreotide therapy.
    Chakravarty AA; Ajmani A; Manchanda S; Kulshreshtha B; Chopra S
    Indian J Endocrinol Metab; 2012 May; 16(3):406-8. PubMed ID: 22629508
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of somatostatin analogue (SMS201-995) on cyclosporine levels.
    Landgraf R; Landgraf-Leurs MM; Nusser J; Hillebrand G; Illner WD; Abendroth D; Land W
    Transplantation; 1987 Nov; 44(5):724-5. PubMed ID: 2891211
    [No Abstract]   [Full Text] [Related]  

  • 72. Biliary colic on abrupt withdrawal of octreotide.
    James RA; Rhodes M; Rose P; Kendall-Taylor P
    Lancet; 1991 Dec; 338(8781):1527. PubMed ID: 1683947
    [No Abstract]   [Full Text] [Related]  

  • 73. Octreotide-induced acute life-threatening gallstones after vicarious contrast medium excretion: A case report.
    Han ZH; He ZM; Chen WH; Wang CY; Wang Q
    World J Clin Cases; 2021 Sep; 9(25):7484-7489. PubMed ID: 34616816
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Side-effects of octreotide withdrawal.
    Sadoul JL; Benchimol D; Thyss A; Freychet P
    Lancet; 1992 Feb; 339(8789):376. PubMed ID: 1346460
    [No Abstract]   [Full Text] [Related]  

  • 75. Prospective study of the long-term effects of somatostatin analog (octreotide) on gallbladder function and gallstone formation in Chinese acromegalic patients.
    Shi YF; Zhu XF; Harris AG; Zhang JX; Dai Q
    J Clin Endocrinol Metab; 1993 Jan; 76(1):32-7. PubMed ID: 8421099
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Acute effect of small dosages of somatostatin analogue SMS201-995 on gallbladder contractility in normal adults].
    Zhu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Jun; 14(3):201-5. PubMed ID: 1394739
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Assessment of gall bladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly.
    Ewins DL; Javaid A; Coskeran PB; Shah S; Butler J; Deprez PH; Miell J; Calam J; Barrett JJ; Dawson JM
    Q J Med; 1992 Apr; 83(300):295-306. PubMed ID: 1631261
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Octreotide-associated biliary tract dysfunction and gallstone formation: pathophysiology and management.
    Redfern JS; Fortuner WJ
    Am J Gastroenterol; 1995 Jul; 90(7):1042-52. PubMed ID: 7611194
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Prospective study of functional changes in the gallbladder and formation of gallstones induced by long-term treatment of somatostatin analogue SMS201-995 in patients of active acromegaly].
    Zhu XF; Shi YF; Zhang JX
    Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):405-8, 455. PubMed ID: 1752152
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.